VEGF inhibition and metastasis Possible implications for antiangiogenic therapy

by Bevin C. English, Douglas K. Price, William D. Figg
Published 2009-08-01

The Role of MRI in Prostate Cancer Active Surveillance

by Linda M. Johnson, Peter L. Choyke, William D. Figg, Baris Turkbey
Published 2014-01-01

Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management

by David K. Doan, Keith T. Schmidt, Cindy H. Chau, William D. Figg
Published 2021-04-01

Precision medicine applications in prostate cancer

by Edel M. McCrea, Daniel K. Lee, Tristan M. Sissung, William D. Figg
Published 2018-06-01

Expression of OATP family members in hormone-related cancers: potential markers of progression.

by Heather Pressler, Tristan M Sissung, David Venzon, Douglas K Price, William D Figg
Published 2011-01-01

A Sensitive and Robust Ultra HPLC Assay with Tandem Mass Spectrometric Detection for the Quantitation of the PARP Inhibitor Olaparib (AZD2281) in Human Plasma for Pharmacokinetic A...

by Jeffrey Roth, Cody J. Peer, Baskar Mannargudi, Helen Swaisland, Jung-Min Lee, Elise C. Kohn, William D. Figg
Published 2014-06-01

Quantification of Temozolomide in Nonhuman Primate Fluids by Isocratic Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry to Study Brain Tissue Penetration Follo...

by Cody J. Peer, Lukas Ronner, Louis Rodgers, Cynthia M. Lester McCully, Katherine E. Warren, William D. Figg
Published 2016-02-01

Reviewing the role of healthy volunteer studies in drug development

by Joyson J. Karakunnel, Nam Bui, Latha Palaniappan, Keith T. Schmidt, Kenneth W. Mahaffey, Briggs Morrison, William D. Figg, Shivaani Kummar
Published 2018-12-01

Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer.

by Tristan M Sissung, Arun Rajan, Gideon M Blumenthal, David J Liewehr, Seth M Steinberg, Arlene Berman, Giuseppe Giaccone, William D Figg
Published 2019-01-01

Important role of CYP2J2 in protein kinase inhibitor degradation: a possible role in intratumor drug disposition and resistance.

by Céline Narjoz, Amélie Favre, Justin McMullen, Philippe Kiehl, Michael Montemurro, William D Figg, Philippe Beaune, Isabelle de Waziers, Bertrand Rochat
Published 2014-01-01

A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy

by Jin Wang, Bertrand Z. Yeung, M. Guillaume Wientjes, Minjian Cui, Cody J. Peer, Ze Lu, William D. Figg, Sukyung Woo, Jessie L.-S. Au
Published 2021-06-01

Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p

by Roberto H. Barbier, Edel M. McCrea, Kristi Y. Lee, Jonathan D. Strope, Emily N. Risdon, Douglas K. Price, Cindy H. Chau, William D. Figg
Published 2021-05-01

Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers.

by Ryszard M Pluta, Edward H Oldfield, Kamran D Bakhtian, Ali Reza Fathi, René K Smith, Hetty L Devroom, Masoud Nahavandi, Sukyung Woo, William D Figg, Russell R Lonser
Published 2011-01-01

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates

by Matthew E Cockman, Kerstin Lippl, Ya-Min Tian, Hamish B Pegg, William D Figg Jnr, Martine I Abboud, Raphael Heilig, Roman Fischer, Johanna Myllyharju, Christopher J Schofield, Peter J Ratcliffe
Published 2019-09-01

The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma

by Sadhana Jackson, Jon Weingart, Edjah K. Nduom, Thura T. Harfi, Richard T. George, Dorothea McAreavey, Xiaobu Ye, Nicole M. Anders, Cody Peer, William D. Figg, Mark Gilbert, Michelle A. Rudek, Stuart A. Grossman
Published 2018-01-01

Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs

by Megan L. Peach, Shaunna L. Beedie, Cindy H. Chau, Matthew K. Collins, Suzana Markolovic, Weiming Luo, David Tweedie, Christian Steinebach, Nigel H. Greig, Michael Gütschow, Neil Vargesson, Marc C. Nicklaus, William D. Figg
Published 2020-12-01

Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models

by Emily M. Harris, Jonathan D. Strope, Shaunna L. Beedie, Phoebe A. Huang, Andrew K. L. Goey, Kristina M. Cook, Christopher J. Schofield, Cindy H. Chau, Melissa M. Cadelis, Brent R. Copp, Kirk R. Gustafson, William D. Figg
Published 2018-07-01

A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women’s cancers with biomarker...

by Alexandra S. Zimmer, Erin Nichols, Ashley Cimino-Mathews, Cody Peer, Liang Cao, Min-Jung Lee, Elise C. Kohn, Christina M. Annunziata, Stanley Lipkowitz, Jane B. Trepel, Rajni Sharma, Lekha Mikkilineni, Margaret Gatti-Mays, William D. Figg, Nicole D. Houston, Jung-Min Lee
Published 2019-07-01

Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)_n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?

by Tristan M. Sissung, Roberto H. Barbier, Douglas K. Price, Teri M. Plona, Kristen M. Pike, Stephanie D. Mellott, Ryan N. Baugher, Gordon R. Whiteley, Daniel R. Soppet, David Venzon, Arlene Berman, Arun Rajan, Giuseppe Giaccone, Paul Meltzer, William D. Figg
Published 2020-01-01

CECs and IL-8 have prognostic and predictive utility in patients with recurrent platinum-sensitive ovarian cancer: biomarker correlates from the randomized phase 2 trial of olapari...

by Jung-Min eLee, Jane B. Trepel, Peter eChoyke, Liang eCao, Tristan M Sissung, Nicole eHouston, Minshu eYu, William D Figg, Ismail eTurkbey, Seth M. Steinberg, Min-Jung eLee, Percy eIvy, Joyce eLiu, Ursula eMatulonis, Elise eKohn
Published 2015-06-01